RIL
RGNX icon

Rothschild Investment LLC’s Regenxbio RGNX Stock Holding History

Rothschild Investment LLC’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.99K Buy
834
+283
+51% +$2.35K ﹤0.01% 1885
2026
Q1 		$4.62K Sell
551
-66
-11% -$693 ﹤0.01% 2091
2025
Q4 		$8.88K Buy
617
+177
+40% +$2.21K ﹤0.01% 1619
2025
Q3 		$4.25K Sell
440
-60
-12% -$531 ﹤0.01% 1778
2025
Q2 		$4.11K Buy
500
+270
+117% +$2.26K ﹤0.01% 1604
2025
Q1 		$1.65K Buy
230
+130
+130% +$967 ﹤0.01% 2021
2024
Q4 		$773 Buy
100
+35
+54% +$329 ﹤0.01% 2368
2024
Q3 		$682 Buy
+65
New +$792 ﹤0.01% 2382
2024
Q2 		– Sell
-5
Closed -$105 – 2843
2024
Q1 		$105 Buy
+5
New +$89 ﹤0.01% 2195

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Rothschild Investment LLC's RGNX Position: Q2 2026 in Review

Rothschild Investment LLC increased its Regenxbio (RGNX) stake by 51% in Q2 2026, buying an estimated $2.35K and bringing the position to 834 shares worth $9.99K. The position accounts for ﹤0.01% of the portfolio, ranked #1885.

Rothschild Investment LLC first reported a position in RGNX in Q1 2024 and has held it in 9 quarters since. 52 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Rothschild Investment LLC held 834 shares of Regenxbio worth $9.99K as of Q2 2026.
  • Rothschild Investment LLC bought 283 Regenxbio shares in Q2 2026, an estimated $2.35K.
  • Regenxbio made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1885 holding.
  • Rothschild Investment LLC first reported a position in Regenxbio in Q1 2024 and has held it in 9 quarters since.
  • 52 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.